{"erythema": 2.55, "guillain-barre syndrome": 6.69, "lymphadenopathy": 2.02, "mobility decreased": 5.64, "musculoskeletal stiffness": 2.29, "nasal congestion": 3.42, "nasopharyngitis": 2.18, "oropharyngeal pain": 3.74, "pain in extremity": 2.49, "peripheral swelling": 2.47, "presyncope": 2.41, "product administered at inappropriate site": 21.38, "rhinorrhoea": 5.77, "urticaria": 2.19, "vaccination site erythema": 5.73, "vaccination site pain": 3.08, "vaccination site swelling": 6.62, "vaccination site warmth": 7.04}